Smithfield Trust’s Quest Diagnostics DGX Stock Holding History

Smithfield Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$199K	Hold	1,018	–	–	0.01%	371
2025 Q4	$176K	Hold	1,018	–	–	0.01%	378
2025 Q3	$193K	Hold	1,018	–	–	0.01%	350
2025 Q2	$182K	Sell	1,018 -5	-0.5%	-$868	0.01%	351
2025 Q1	$173K	Sell	1,023 -172	-14%	-$28.3K	0.01%	364
2024 Q4	$180K	Hold	1,195	–	–	0.01%	355
2024 Q3	$186K	Hold	1,195	–	–	0.01%	352
2024 Q2	$163K	Hold	1,195	–	–	0.01%	353
2024 Q1	$159K	Hold	1,195	–	–	0.01%	366
2023 Q4	$164K	Sell	1,195 -208	-15%	-$27.3K	0.01%	340
2023 Q3	$171K	Hold	1,403	–	–	0.01%	322
2023 Q2	$197K	Sell	1,403 -52	-4%	-$7.17K	0.01%	311
2023 Q1	$205K	Hold	1,455	–	–	0.01%	293
2022 Q4	$228K	Hold	1,455	–	–	0.02%	271
2022 Q3	$179K	Buy	1,455 +260	+22%	+$34.2K	0.01%	292
2022 Q2	$159K	Hold	1,195	–	–	0.01%	325
2022 Q1	$163K	Hold	1,195	–	–	0.01%	345
2021 Q4	$207K	Hold	1,195	–	–	0.01%	319
2021 Q3	$175K	Hold	1,195	–	–	0.01%	337
2021 Q2	$157K	Hold	1,195	–	–	0.01%	356
2021 Q1	$153K	Hold	1,195	–	–	0.01%	364
2020 Q4	$142K	Buy	1,195 +25	+2%	+$3.05K	0.01%	367
2020 Q3	$134K	Sell	1,170 -25	-2%	-$2.95K	0.01%	354
2020 Q2	$136K	Buy	1,195 +25	+2%	+$2.65K	0.01%	335
2020 Q1	$94K	Hold	1,170	–	–	0.01%	343
2019 Q4	$125K	Hold	1,170	–	–	0.01%	361
2019 Q3	$125K	Hold	1,170	–	–	0.01%	353
2019 Q2	$119K	Hold	1,170	–	–	0.01%	366
2019 Q1	$105K	Hold	1,170	–	–	0.01%	374
2018 Q4	$97K	Hold	1,170	–	–	0.01%	355
2018 Q3	$126K	Sell	1,170 -54	-4%	-$5.92K	0.01%	363
2018 Q2	$135K	Buy	1,224 +54	+5%	+$5.63K	0.02%	338
2018 Q1	$117K	Sell	1,170 -1,432	-55%	-$147K	0.01%	369
2017 Q4	$256K	Sell	2,602 -2,326	-47%	-$221K	0.03%	234
2017 Q3	$461K	Sell	4,928 -210	-4%	-$22.3K	0.06%	167
2017 Q2	$571K	Sell	5,138 -219	-4%	-$23.2K	0.08%	137
2017 Q1	$526K	Sell	5,357 -170	-3%	-$16.2K	0.08%	144
2016 Q4	$508K	Sell	5,527 -612	-10%	-$52.7K	0.09%	152
2016 Q3	$520K	Buy	6,139 +2,387	+64%	+$200K	0.09%	126
2016 Q2	$305K	Buy	3,752 +1,700	+83%	+$129K	0.06%	193
2016 Q1	$147K	Hold	2,052	–	–	0.03%	320
2015 Q4	$146K	Buy	2,052 +281	+16%	+$18.9K	0.03%	321
2015 Q3	$109K	Hold	1,771	–	–	0.02%	359
2015 Q2	$128K	Buy	1,771 +81	+5%	+$5.98K	0.03%	349
2015 Q1	$130K	Buy	+1,690	New	+$121K	0.03%	364

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Smithfield Trust's DGX Position: Q1 2026 in Review

Smithfield Trust held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,018 shares worth $199K. The position accounts for 0.01% of the portfolio, ranked #371.

Smithfield Trust first reported a position in DGX in Q1 2015 and has held it in 45 quarters since. The position peaked at $571K in Q2 2017. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Smithfield Trust held 1,018 shares of Quest Diagnostics worth $199K as of Q1 2026.
Smithfield Trust left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up 0.01% of Smithfield Trust's portfolio in Q1 2026, its #371 holding.
Smithfield Trust first reported a position in Quest Diagnostics in Q1 2015 and has held it in 45 quarters since.
Smithfield Trust's Quest Diagnostics position peaked at $571K in Q2 2017.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.